Andere Sprachen PainReform Ltd.

Aktien

A2QB4E

IL0011651580

PRFX

Markt geschlossen - Nasdaq Andere Börsenplätze 22:30:00 03.05.2024			% 5 Tage	% 1. Jan.
0.821 ^USD	-10.76%		+1.35%	-70.15%

16.04.	PainReform gibt Preis für $4 Millionen Angebot vor; Aktien fallen vor der Glocke	MT
09.04.	Painreform Ltd. gibt bahnbrechende Ergebnisse neuer Studien bekannt, die die überragenden In-vitro-Freisetzungsraten von PRF-110 belegen	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

PainReform Announces Closing of $4 Million Public Offering	18.04.
PainReform Prices $4 Million Offering; Shares Tumble Pre-Bell	16.04.
PainReform Announces Pricing of $4 Million Public Offering	16.04.
PainReform : CEO IlanHadar Interviewed on “The Big Biz Show”	14.04.
Painreform Ltd. Announces Groundbreaking Results from New Studies Demonstrating the Superior In-Vitro Release Rates of PRF-110	09.04.
PainReform : Non-Opiate Topical Treatment for Post-Surgical Pain Relief Outperforms Leading Competitor Under Various Testing Conditions	09.04.
PainReform Reaches 50% Enrollment in the Second Part of its Phase 3 Clinical Trial of PRF-110 in Bunionectomy	02.04.
PainReform Ltd. Reaches 50% Enrollment in the Second Part of its Phase 3 Clinical Trial of PRF-110 in Bunionectomy	02.04.
PainReform : NOTICE OF EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS - Form 6-K	07.03.
PainReform : Investors Presentation – March 2024	03.03.
PainReform Provides Year-End Business Update	01.03.
PainReform Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	29.02.
PainReform to Present at the Microcap Conference in Atlantic City	22.01.
PainReform to Present at the Microcap Conference in Atlantic City	22.01.
PainReform Reports Successful Head-to-Head Comparison of PRF-110 Versus Market Leading Post Surgical Analgesia for Extended Postoperative Pain Relief	03.01.
PainReform Reports Successful Head-to-Head Comparison of PRF-110 Versus Market Leading Post Surgical Analgesia for Extended Postoperative Pain Relief	03.01.
PainReform Announces Exercise of Warrants for Approximately $1.3 Million in Gross Proceeds	27.12.
PainReform : Condensed Statements of Changes in Shareholders’ Equity - Form 6-K	15.11.
PainReform Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	15.11.
PainReform Provides Business Update for the Third Quarter of 2023	15.11.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen PainReform Ltd.

Aktien

A2QB4E

IL0011651580

PRFX

Andere Sprachen

Filter